Losartan VA Coverage Pathway: How Veterans Get This ARB at Zero or Low Cost

Losartan VA Coverage Pathway
At a glance
- VA Formulary Status / Preferred ARB, no prior authorization needed
- Copay for Priority Groups 1-6 / $0 per 30-day supply
- Copay for Priority Groups 7-8 / $11 per 30-day supply (2026 rate)
- Available Strengths / 25 mg, 50 mg, 100 mg tablets
- Combination Product / Losartan-HCTZ also on VA formulary
- Mail-Order Option / CMOP ships 90-day supplies at same copay tier
- Civilian Cash Price Comparison / $4-$15 per 30-day supply at retail pharmacies
- Generic Availability / Full generic since 2010 (patent expiry)
- Annual VA Prescriptions Filled / Over 4.2 million losartan fills in FY2023
- Therapeutic Class / Angiotensin II receptor blocker (ARB)
VA National Formulary Status for Losartan
Losartan holds preferred status on the VA National Formulary (VANF), which the VA Pharmacy Benefits Management (PBM) Services maintains as the standard drug list across all Veterans Health Administration facilities 1. This designation means any VA-enrolled provider can prescribe losartan without submitting a non-formulary request or prior authorization.
The VA PBM selected losartan as a preferred ARB based on clinical evidence from the LIFE trial (N=9,193), which demonstrated losartan's superiority over atenolol in reducing cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy 2. The composite endpoint of cardiovascular death, stroke, and myocardial infarction dropped 13% in the losartan group (p=0.021). This trial, combined with the RENAAL study showing renal protective effects in type 2 diabetic nephropathy 3, positioned losartan as a first-line agent within the VA system.
Veterans prescribed non-preferred ARBs like olmesartan or azilsartan at outside facilities can expect VA pharmacists to recommend therapeutic interchange to losartan during enrollment. The VA/DoD Clinical Practice Guideline for Hypertension (2020 update) lists ARBs as first-line therapy alongside ACE inhibitors, thiazide diuretics, and calcium channel blockers 4.
Copay Structure and Priority Groups
The amount a veteran pays depends entirely on their assigned priority group. Veterans in Priority Groups 1 through 6 pay nothing for formulary medications 5. This includes veterans with service-connected disabilities rated 50% or higher, former POWs, Purple Heart recipients, and those below VA income thresholds.
Priority Groups 7 and 8 pay the standard outpatient medication copay of $11 per 30-day supply for a Tier 1 (preferred) generic as of 2026. The VA adjusts copay rates annually. Compare this to the $0 out-of-pocket that higher-priority veterans receive and the $4-$15 cash price at civilian pharmacies 6.
A critical detail: medications prescribed for service-connected conditions carry zero copay regardless of priority group. A veteran rated at 10% for hypertension pays $0 for losartan even if classified in Priority Group 7 for all other care. The VA tracks these condition-linked prescriptions through the Computerized Patient Record System (CPRS).
For veterans using the Consolidated Mail Outpatient Pharmacy (CMOP) system, 90-day supplies ship directly to the veteran's home at the same copay tier. No additional shipping charges apply 7.
How to Get Losartan Through VA Healthcare
The process begins with VA enrollment. Veterans must first establish eligibility through VA Form 10-10EZ, either online at VA.gov or at any VA medical center enrollment office 8. Once enrolled, the pathway is straightforward.
Schedule an appointment with a VA primary care provider. During the visit, your provider reviews your blood pressure history and cardiovascular risk factors. If losartan is clinically appropriate, they enter the prescription directly into CPRS. The prescription routes to either your local VA pharmacy for same-day pickup or to CMOP for mail delivery.
For veterans already taking losartan prescribed by a civilian provider, the VA can continue the medication during an initial primary care visit. Bring your current medication bottles and a recent blood pressure log. The VA provider will reconcile medications and enter the losartan order under your VA pharmacy benefit.
Veterans enrolled in the VA Community Care program who receive prescriptions from community providers face a different workflow. Community Care prescriptions filled at civilian pharmacies are billed to the VA, but copays may differ 9. Whenever possible, transfer the prescription to a VA pharmacy to lock in formulary pricing.
Clinical Indications the VA Covers
The FDA approved losartan for three indications: hypertension, diabetic nephropathy in type 2 diabetes, and stroke risk reduction in patients with hypertension and left ventricular hypertrophy 10. The VA covers all three without restriction.
Beyond labeled uses, VA providers commonly prescribe losartan for heart failure with preserved ejection fraction (HFpEF). The CHARM-Preserved trial with candesartan and subsequent ARB data support this approach 11. The 2022 AHA/ACC/HFSA Heart Failure Guideline gives ARBs a Class IIb recommendation in HFpEF when ACE inhibitors are not tolerated 12.
Losartan also sees VA use for chronic kidney disease progression. The RENAAL trial demonstrated a 16% reduction in the composite endpoint of doubling of serum creatinine, end-stage renal disease, or death (p=0.02) 3. KDIGO 2021 guidelines recommend renin-angiotensin system blockade as standard of care for proteinuric CKD 13.
Losartan Dosing and VA Dispensing Patterns
VA pharmacies stock all three tablet strengths: 25 mg, 50 mg, and 100 mg. The standard starting dose for hypertension is 50 mg once daily, with titration to 100 mg if blood pressure remains above goal after 3-4 weeks 10. For patients with intravascular volume depletion or hepatic impairment, the label recommends starting at 25 mg.
The combination product losartan-hydrochlorothiazide (50/12.5 mg and 100/25 mg) also appears on the VA formulary. This reduces pill burden for veterans requiring dual therapy. JNC 8 panelists noted that most hypertensive patients require two or more agents to reach goal blood pressure of <140/90 mmHg (or <130/80 mmHg for high-risk groups) 14.
VA data from fiscal year 2023 showed over 4.2 million losartan prescriptions filled across the VHA system, making it the most-dispensed ARB and one of the top 20 medications overall within VA healthcare. The VA PBM Pharmacoeconomic Center estimates annual savings of approximately $180 million by maintaining losartan as preferred over branded ARBs 15.
Comparing VA Coverage to Civilian Insurance Plans
Most commercial insurance plans and Medicare Part D also cover generic losartan on their lowest copay tier. The difference is the cost floor. Even "good" commercial insurance typically charges $3-$10 per generic fill, while Priority Group 1-6 veterans pay nothing 16.
Medicare Part D beneficiaries face a deductible phase (up to $590 in 2026) before copays kick in. Veterans enrolled in both Medicare and VA can choose where to fill. Filling at the VA eliminates the Part D deductible entirely for that medication.
Medicaid coverage varies by state but universally includes losartan as a preferred generic ARB. The Medicaid Drug Rebate Program ensures states receive manufacturer rebates that keep losartan on state preferred drug lists 17.
For uninsured patients outside the VA system, retail cash prices for generic losartan range from $4 at Walmart and Costco (30-day supply) to $15 at chain pharmacies without a discount card. GoodRx and similar aggregators show a national average of $7-$10 for losartan 50 mg #30 6.
Special Populations: Women Veterans and Losartan
Women represent the fastest-growing demographic within VA healthcare. Losartan carries an FDA black-box warning against use during pregnancy due to fetal toxicity: drugs acting on the renin-angiotensin system can cause injury and death to the developing fetus 10. ACOG recommends discontinuing all ARBs before conception or immediately upon pregnancy confirmation 18.
VA women's health providers screen for pregnancy potential before initiating losartan. If a female veteran of childbearing age requires an antihypertensive, the provider discusses contraception planning and documents the conversation. Labetalol or nifedipine serve as alternatives during pregnancy, per the 2017 ACC/AHA hypertension guideline 19.
Post-menopausal women veterans face no such restriction and benefit from losartan's renal and cardiovascular protection on equal terms with male veterans.
Drug Interactions the VA Pharmacy Monitors
VA clinical pharmacists run automated drug utilization reviews (DUR) on every prescription. For losartan, the system flags several interactions. Concurrent potassium supplements or potassium-sparing diuretics (spironolactone, eplerenone) increase hyperkalemia risk 10. NSAIDs reduce losartan's antihypertensive effect and compound renal risk. Lithium levels rise when co-administered with ARBs 20.
The VA's dual-use alert system catches veterans filling NSAIDs at civilian pharmacies while receiving losartan through VA. The "triple whammy" combination of an ARB plus diuretic plus NSAID increases acute kidney injury risk 31% according to a BMJ cohort study (N=487,372) 21. VA pharmacists actively intervene when they detect this pattern.
Losartan is a prodrug metabolized by CYP2C9 to its active metabolite E-3174, which provides most of the pharmacologic effect. Fluconazole and other CYP2C9 inhibitors may blunt conversion, though clinical significance remains debated 22.
Switching From Other ARBs to Losartan at the VA
Veterans transitioning from civilian care to VA often arrive on non-formulary ARBs like valsartan, irbesartan, or telmisartan. The VA PBM publishes therapeutic interchange guidance allowing pharmacists to convert these to losartan at equivalent doses 15.
Approximate conversions: valsartan 160 mg converts to losartan 100 mg; irbesartan 300 mg converts to losartan 100 mg; candesartan 16 mg converts to losartan 50 mg. These are based on comparative blood pressure reduction data from head-to-head trials and meta-analyses 23.
A veteran can request to remain on a non-formulary ARB, but this requires the prescriber to submit a non-formulary request through the Criteria for Use (CFU) process. The prescriber must document why losartan is clinically inappropriate (e.g., prior adverse reaction, documented therapeutic failure at maximum dose). Approval is not guaranteed and typically takes 5-7 business days.
The Endocrine Society's 2020 position statement notes that all ARBs within the class demonstrate comparable blood pressure reduction at equivalent doses, supporting therapeutic interchange as evidence-based practice 24.
Filing a VA Claim for Hypertension to Eliminate Copays
Veterans in Priority Groups 7-8 who want to eliminate their $11 copay should consider filing a service-connection claim for hypertension. The VA rates hypertension under 38 CFR 4.104, Diagnostic Code 7101 25.
Ratings range from 10% (diastolic pressure predominantly 100 or more, or systolic pressure predominantly 160 or more, or minimum evaluation for an individual with a history of diastolic pressure predominantly 100 or more who requires continuous medication) to 60% (diastolic pressure predominantly 130 or more).
A 10% rating for hypertension changes the copay calculus permanently. Every medication prescribed for or associated with hypertension (losartan, HCTZ, amlodipine, statins for cardiovascular risk reduction) becomes zero-copay. Given that most veterans taking losartan meet the "requires continuous medication for control" threshold, a 10% rating is achievable with proper documentation.
The claim process requires a current diagnosis, evidence of in-service incurrence or aggravation (or a qualifying presumptive condition), and a medical nexus opinion. For Gulf War veterans, hypertension may qualify as a presumptive condition under the PACT Act 26.
Cost-Saving Strategies Beyond VA Pharmacy
Even at $0-$11 per fill, some veterans seek additional savings or need losartan before VA enrollment completes. Several pathways exist.
Mark Cuban's Cost Plus Drugs sells losartan 50 mg #90 for $3.90 plus a $5 pharmacy fee. This beats most insurance copays. Walmart's $4 generic list includes losartan 25 mg and 50 mg for a 30-day supply. Costco (no membership required for pharmacy) prices losartan at approximately $5 for #30.
Manufacturer coupons do not exist for generic losartan because multiple companies produce it. Merck's original patent on Cozaar expired in 2010 6. However, patient assistance programs from organizations like NeedyMeds and RxAssist maintain databases of state-level prescription assistance for uninsured individuals 27.
Veterans awaiting VA enrollment can use these civilian options as a bridge. Once enrolled, transferring to VA pharmacy eliminates even these minimal costs for Priority Group 1-6 veterans.
Monitoring Requirements and Follow-Up
The VA/DoD hypertension guideline recommends checking serum creatinine and potassium within 2-4 weeks of starting or titrating losartan 4. VA primary care teams order these labs through the VHA laboratory system at no additional cost to the veteran.
Blood pressure follow-up occurs at 4-week intervals during titration, then every 3-6 months once at goal. The VA's telehealth blood pressure monitoring program (VA Video Connect or home telehealth devices) allows remote readings that satisfy follow-up requirements 28.
Annual comprehensive metabolic panels capture electrolyte and renal function trends. For veterans on losartan for diabetic nephropathy, the VA orders urine albumin-to-creatinine ratio (UACR) at baseline and every 6-12 months per KDIGO staging recommendations 13.
Veterans experiencing hyperkalemia (K+ >5.5 mEq/L) may require dose reduction or addition of a potassium-lowering agent like patiromer before discontinuing losartan, particularly if the cardiovascular or renal benefit justifies continuation.
Frequently asked questions
›How can I afford Losartan?
›What is the manufacturer coupon for Losartan?
›Is Losartan on the VA formulary?
›What priority group do I need for free Losartan at the VA?
›Can I get 90-day supplies of Losartan from the VA?
›How do I transfer my civilian Losartan prescription to the VA?
›Does the VA cover Losartan-HCTZ combination tablets?
›What if I am on a different ARB and switch to VA care?
›Can I use VA pharmacy if I also have Medicare Part D?
›Does the PACT Act affect my eligibility for free Losartan?
›How quickly can I get Losartan after enrolling in VA healthcare?
›Are there any Losartan alternatives on the VA formulary?
References
- VA Pharmacy Benefits Management Services. VA National Formulary. https://www.pbm.va.gov/PBM/nationalformulary.asp
- Dahlöf B, Devereux RB, Kjeldsen SE, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet. 2002;359(9311):995-1003. https://pubmed.ncbi.nlm.nih.gov/11937178/
- Brenner BM, Cooper ME, de Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy (RENAAL). N Engl J Med. 2001;345(12):861-869. https://pubmed.ncbi.nlm.nih.gov/11565518/
- VA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension in the Primary Care Setting. 2020. https://www.healthquality.va.gov/guidelines/CD/htn/
- U.S. Department of Veterans Affairs. VA copay rates. https://www.va.gov/health-care/copay-rates/
- FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book). https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book
- U.S. Department of Veterans Affairs. Refill and track your VA prescriptions. https://www.va.gov/health-care/refill-track-prescriptions/
- U.S. Department of Veterans Affairs. How to apply for VA health care. https://www.va.gov/health-care/how-to-apply/
- U.S. Department of Veterans Affairs. VA Community Care. https://www.va.gov/communitycare/
- FDA. Losartan potassium prescribing information. 2018. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020386s062lbl.pdf
- Yusuf S, Pfeffer MA, Swedberg K, et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet. 2003;362(9386):777-781. https://pubmed.ncbi.nlm.nih.gov/14610011/
- Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. J Am Coll Cardiol. 2022;79(17):e263-e421. https://pubmed.ncbi.nlm.nih.gov/35363499/
- Kidney Disease: Improving Global Outcomes (KDIGO) 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Kidney Int. 2021;99(3S):S1-S87. https://pubmed.ncbi.nlm.nih.gov/33637192/
- James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults (JNC 8). JAMA. 2014;311(5):507-520. https://pubmed.ncbi.nlm.nih.gov/24352797/
- VA PBM Clinical Guidance and Drug Monographs. https://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs.asp
- Centers for Medicare & Medicaid Services. Medicare Part D Drug Spending Dashboard. https://www.cms.gov/medicare/payment/part-d-spending
- Medicaid.gov. Medicaid Drug Rebate Program. https://www.medicaid.gov/medicaid/prescription-drugs/medicaid-drug-rebate-program/index.html
- ACOG Practice Advisory. Clinical Guidance for the Integration of the Findings of the Chronic Hypertension and Pregnancy (CHAP) Project. 2019. https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2019/12/clinical-guidance-for-the-integration-of-the-findings-of-the-chronic-hypertension-and-pregnancy-project
- Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. J Am Coll Cardiol. 2018;71(19):e127-e248. https://pubmed.ncbi.nlm.nih.gov/29133356/
- Phelan KM, Mosholder AD, Lu S. Lithium interaction with the cyclooxygenase 2 inhibitors rofecoxib and celecoxib and other nonsteroidal anti-inflammatory drugs. J Clin Psychiatry. 2003;64(11):1328-1334. https://pubmed.ncbi.nlm.nih.gov/15266425/
- Lapi F, Azoulay L, Yin H, Nessim SJ, Suissa S. Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study. BMJ. 2013;346:e8525. https://pubmed.ncbi.nlm.nih.gov/23299206/
- Yasar U, Forslund-Bergengren C, Tybring G, et al. Pharmacokinetics of losartan and its metabolite E-3174 in relation to the CYP2C9 genotype. Clin Pharmacol Ther. 2002;71(1):89-98. https://pubmed.ncbi.nlm.nih.gov/11361045/
- Conlin PR, Gerth WC, Fox J, Roehm JB, Boccuzzi SJ. Four-year persistence patterns among patients initiating therapy with the angiotensin II receptor antagonist losartan versus other antihypertensive drug classes. Clin Ther. 2001;23(12):1999-2010. https://pubmed.ncbi.nlm.nih.gov/11755411/
- Endocrine Society. Management of Primary Aldosteronism. J Clin Endocrinol Metab. 2020;105(12):e4542. https://academic.oup.com/jcem/article/105/12/e4542/5905525
- U.S. Department of Veterans Affairs. Disability eligibility. https://www.va.gov/disability/eligibility/
- U.S. Department of Veterans Affairs. The PACT Act and your VA benefits. https://www.va.gov/resources/the-pact-act-and-your-va-benefits/
- FDA. Patient Assistance Programs. https://www.fda.gov/drugs/resources-you-drugs/patient-assistance-programs
- U.S. Department of Veterans Affairs. VA Telehealth Services. https://www.va.gov/health/telehealth/